MYOM2 and ulcer disease: Thus, the ability of GmPcides to inhibit expression of SpeB, M protein, and other virulence factors may have contributed to PS757’s ability to treat SSTI by reducing tissue damage, accelerating bacterial clearance, stimulating ulcer healing, and alleviating host inflammation to promote a quicker recovery.